Source: Annual Congress 2005 - Assessment of lung function and side-effects in various diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Madsen, M. Christensen, L. Frolund, U. S. Petersen, A. Frost (Glostup, Denmark). Sentinel surveillance of risk associated with specific allergy vaccination (SAV). Quality assurance of a clinical procedure with few but serious side effects. Eur Respir J 2005; 26: Suppl. 49, 3414

Member's Comments

No comment yet.

Related content which might interest you: Clinical and epidemiological assessment of the regional program of vaccination for pneumococcal infections Source: International Congress 2016 – Monitoring comorbidities Year: 2016 A follow-up of patients with a new diagnosis of asthma - characteristics, prognosis and risk factors Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Suboptimal asthma control: prevalence, detection and consequences in general practice Source: Eur Respir J 2008; 31: 320-325 Year: 2008 Effect of implementing a web-based application for spirometry quality control in a public health system. A 10-year prospective study, including the covid-19 pandemic. Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities Year: 2021 Factors influencing on influenza vaccination among chronic obstructive pulmonary disease: The Korea national health and nutrition examination survey Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Predicting sensitization and allergy in bakery workers participating a surveillance programme Source: International Congress 2015 – Work, environment and the epidemiology of asthma Year: 2015 Evaluation of nationwide quality control indicators of asthma treatment Source: International Congress 2018 – Asthma and drugs Year: 2018 The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Added value of electronic monitoring in the assessment of asthma control? Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Tuberculosis treatment outcome monitoring in European Union countries: systematic review Source: Eur Respir J 2013; 41: 635-643 Year: 2013 Best practices in integrating home spirometer measurements with electronic clinical outcome assessments (eCOA) in clinical trials Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Low real-world utility of IGRA when screening for LTBI in a low incidence setting Source: International Congress 2015 – Screening strategies in TB Year: 2015 Quality standards for the management of bronchiectasis in Italy: a national audit Source: Eur Respir J 2016; 48: 244-248 Year: 2016 Impact of a disease management program on control and cost of asthma in Normandy Source: Eur Respir J 2005; 26: Suppl. 49, 47s Year: 2005 Evaluation of a diagnostic–therapeutic pathway on GINA guidelines between specialist and primary care physicians. Study and result at 1 year in children with asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Improvement patient safety during lung function testing through the implementation of a safety checklist Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020 Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Evidence of variation to drive quality improvement: The NHS atlas of variation in respiratory healthcare Source: Annual Congress 2013 –Is it really asthma? Year: 2013